U.S. drug regulators unmoved by Pfizer plan to seek Covid booster authorization
Dow Jones2021-07-09
MW U.S. drug regulators unmoved by Pfizer plan to seek Covid booster authorization
In an unusual exchange, the Food and Drug Administration and the Center for Disease Control on Thursday said there isn't scientific evidence that COVID-19 booster shots are required, hours after drug maker Pfizer $(PFE)$ said it would seek authorization for a Covid booster shot to help contain the Delta variant.
The outlook: The race between vaccines and the virus is still on. Meanwhile, as Daly noted, large parts of the world remain unvaccinated, a major headwind on global growth.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
